BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34667015)

  • 1. Healthcare resource utilisation and costs associated with a heart failure diagnosis: a retrospective, population-based cohort study in Sweden.
    Boman K; Lindmark K; Stålhammar J; Olofsson M; Costa-Scharplatz M; Fonseca AF; Johansson S; Heller V; Törnblom M; Wikström G
    BMJ Open; 2021 Oct; 11(10):e053806. PubMed ID: 34667015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resource utilisation and outcomes of people with heart failure in England: a descriptive analysis of linked primary and secondary care data - the PULSE study.
    Linden S; Gollop ND; Farmer R
    Open Heart; 2023 Dec; 10(2):. PubMed ID: 38070884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of preserved ejection fraction heart failure in a real-world Swedish patient population.
    Stålhammar J; Stern L; Linder R; Sherman S; Parikh R; Ariely R; Deschaseaux C; Wikström G
    J Med Econ; 2014 Jan; 17(1):43-51. PubMed ID: 24066839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plans.
    Lam CSP; Wood R; Vaduganathan M; Bueno H; Chin A; Luporini Saraiva G; Sörstadius E; Tritton T; Thomas J; Qin L
    Clin Cardiol; 2021 May; 44(5):646-655. PubMed ID: 33704817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients.
    Stålhammar J; Stern L; Linder R; Sherman S; Parikh R; Ariely R; Wikström G
    J Med Econ; 2012; 15(5):938-46. PubMed ID: 22510016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program.
    Murphy TM; Waterhouse DF; James S; Casey C; Fitzgerald E; O'Connell E; Watson C; Gallagher J; Ledwidge M; McDonald K
    Int J Cardiol; 2017 Apr; 232():330-335. PubMed ID: 28087180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions.
    Olchanski N; Vest AR; Cohen JT; Neumann PJ; DeNofrio D
    Int J Cardiol; 2018 Jun; 261():103-108. PubMed ID: 29657034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction.
    Huusko J; Purmonen T; Toppila I; Lassenius M; Ukkonen H
    ESC Heart Fail; 2020 Jun; 7(3):1039-1048. PubMed ID: 32187879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and mortality of patients with heart failure in Southern Sweden from 2013 to 2019: a population-based cohort study.
    Davidge J; Ashfaq A; Ødegaard KM; Olsson M; Costa-Scharplatz M; Agvall B
    BMJ Open; 2022 Dec; 12(12):e064997. PubMed ID: 36526318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.
    Ergatoudes C; Schaufelberger M; Andersson B; Pivodic A; Dahlström U; Fu M
    Clin Res Cardiol; 2019 Sep; 108(9):1025-1033. PubMed ID: 30788622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
    Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
    JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of algorithms for determining heart failure with reduced and preserved ejection fraction using nationwide electronic healthcare records in the UK.
    Sundaram V; Zakeri R; Witte KK; Quint JK
    Open Heart; 2022 Nov; 9(2):. PubMed ID: 36332942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year outcomes and cost for heart failure patients following discharge from the hospital after an acute heart failure admission.
    Olchanski N; Vest AR; Cohen JT; DeNofrio D
    Int J Cardiol; 2020 May; 307():109-113. PubMed ID: 31748189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction.
    Dalén M; Lund LH; Ivert T; Holzmann MJ; Sartipy U
    JAMA Cardiol; 2016 Aug; 1(5):530-8. PubMed ID: 27434816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prevalence of heart failure in England: a descriptive analysis of linked primary and secondary care data - the PULSE study.
    Bellanca L; Linden S; Farmer R
    BMC Cardiovasc Disord; 2023 Jul; 23(1):374. PubMed ID: 37495953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in cause-specific readmissions in heart failure with preserved vs. reduced and mid-range ejection fraction.
    Cui X; Thunström E; Dahlström U; Zhou J; Ge J; Fu M
    ESC Heart Fail; 2020 Oct; 7(5):2894-2903. PubMed ID: 32729678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.